Text Size

Modulation of Inflammation-Related Genes in the Cornea of a Mouse Model of Dry Eye upon Treatment with Cyclosporine Eye Drops

Daull P., Barabino S., Feraille L., Kessal K., Docquier M., Parsadaniantz S.M., Baudouin C., Garrigue J.-S.

  • 2019
  • Current Eye Research
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Technology


  • Categories

    Preclinical development

  • Affiliations

    Novagali Innovation Center, SANTEN SAS, Novagali Innovation Center, Evry Cedex, France; Ocular Surface & Dry Eye Center, Ospedale L. Sacco, University of Milan, Milan, Italy; Iris Pharma, Les Nertières, Allée Hector Pintus, La Gaude, France; Vision Institute UMR S 968, UMR 7210 CNRS, Paris Sorbonne Universités, Paris, France; iGE3, University of Geneva Medical School, Geneva 4, Switzerland; CHNO XV-XX Hospital, Paris, France

Related Publications

Burden of Vernal Keratoconjunctivitis in the United States: A Retrospective Claims Database Analysis

Koo E.B.; Yu T.M.; Layton A.J.; Babineaux S.; Fung S.

Review of clinical outcomes of a cationic emulsion tear substitute in patients with dry eye disease

Labetoulle M, Garhöfer G, Ismail D, Garrigue JS, Amrane M, Guillon M, Aragona P, Baudouin C.

Epinastine Cream: A Novel Once-Daily Therapeutic Agent for Allergic Conjunctivitis

Ogura N., Fujisawa K., Kato M.

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022